284 related articles for article (PubMed ID: 25447675)
1. Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
Krisenko MO; Geahlen RL
Biochim Biophys Acta; 2015 Jan; 1853(1):254-63. PubMed ID: 25447675
[TBL] [Abstract][Full Text] [Related]
2. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
Wang HY; Zhang ZX
Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
[TBL] [Abstract][Full Text] [Related]
3. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression.
Coopman PJ; Mueller SC
Cancer Lett; 2006 Sep; 241(2):159-73. PubMed ID: 16442709
[TBL] [Abstract][Full Text] [Related]
4. Nonredundant roles of Src-family kinases and Syk in the initiation of B-cell antigen receptor signaling.
Stepanek O; Draber P; Drobek A; Horejsi V; Brdicka T
J Immunol; 2013 Feb; 190(4):1807-18. PubMed ID: 23335753
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
6. The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes.
van Oers NS; Weiss A
Semin Immunol; 1995 Aug; 7(4):227-36. PubMed ID: 8520027
[TBL] [Abstract][Full Text] [Related]
7. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
9. Spleen tyrosine kinase mediates BEAS-2B cell migration and proliferation and human rhinovirus-induced expression of vascular endothelial growth factor and interleukin-8.
Wang X; Mychajlowycz M; Lau C; Gutierrez C; Scott JA; Chow CW
J Pharmacol Exp Ther; 2012 Feb; 340(2):277-85. PubMed ID: 22031919
[TBL] [Abstract][Full Text] [Related]
10. Role of protein-tyrosine kinase syk in oxidative stress signaling in B cells.
Takano T; Sada K; Yamamura H
Antioxid Redox Signal; 2002 Jun; 4(3):533-41. PubMed ID: 12215221
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
[TBL] [Abstract][Full Text] [Related]
12. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
14. Identification of BCAR-1 as a new substrate of Syk tyrosine kinase through a determination of amino acid sequence preferences surrounding the substrate tyrosine residue.
Kim JY; Huh K; Jung R; Kim TJ
Immunol Lett; 2011 Mar; 135(1-2):151-7. PubMed ID: 21047529
[TBL] [Abstract][Full Text] [Related]
15. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
[TBL] [Abstract][Full Text] [Related]
16. A peptide-based biosensor assay to detect intracellular Syk kinase activation and inhibition.
Lipchik AM; Killins RL; Geahlen RL; Parker LL
Biochemistry; 2012 Sep; 51(38):7515-24. PubMed ID: 22920457
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways.
Park GB; Kim D; Kim YS; Kim S; Lee HK; Yang JW; Hur DY
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1770-9. PubMed ID: 24569586
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
19. The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.
Zhou Q; Geahlen RL
Oncogene; 2009 Mar; 28(10):1348-56. PubMed ID: 19151749
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase.
Xu JW; Morita I; Ikeda K; Miki T; Yamori Y
Mol Endocrinol; 2007 Feb; 21(2):564-73. PubMed ID: 17095576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]